Sanara Total Assets vs Net Tangible Assets Analysis

SMTI Stock

USD 35.91 0.71 1.94%

Sanara Medtech financial indicator trend analysis is much more than just breaking down Sanara Medtech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sanara Medtech is a good investment. Please check the relationship between Sanara Medtech Total Assets and its Net Tangible Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

Total Assets vs Net Tangible Assets

Total Assets vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sanara Medtech Total Assets account and Net Tangible Assets. At this time, the significance of the direction appears to have strong relationship.

The correlation between Sanara Medtech's Total Assets and Net Tangible Assets is 0.62. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Sanara Medtech, assuming nothing else is changed. The correlation between historical values of Sanara Medtech's Total Assets and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Sanara Medtech are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Total Assets i.e., Sanara Medtech's Total Assets and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

0.62

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Assets

Total assets refers to the total amount of Sanara Medtech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sanara Medtech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most indicators from Sanara Medtech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sanara Medtech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.As of now, Sanara Medtech's Selling General Administrative is increasing as compared to previous years. Tax Provision is expected to grow at the current pace this year, while Issuance Of Capital Stock is projected to decrease to under 982.1 K.

	2021	2022	2023	2024 (projected)
Total Revenue	24.1M	45.8M	65.0M	68.2M
Interest Expense	711.0	284.7K	475.8K	499.6K

Total Revenue Interest Expense

Sanara Medtech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Inventory	Common Stock Total Equity	Property Plant And Equipment Gross	Current Deferred Revenue
Total Assets		0.76	0.95	0.94	0.99	0.98	-0.02	0.26	0.97	0.58	0.98	-0.86	0.58	0.99	0.92	0.9	0.8	0.7	0.95	0.9	-0.07	-0.58	0.99	-0.53	0.99	0.75
Short Long Term Debt Total	0.76		0.66	0.72	0.67	0.74	0.54	-0.01	0.83	0.09	0.83	-0.36	0.09	0.77	0.56	0.94	0.26	0.61	0.87	0.49	0.17	-0.32	0.8	-0.28	0.78	0.51
Other Current Liab	0.95	0.66		0.98	0.92	0.91	-0.03	0.28	0.89	0.52	0.93	-0.85	0.52	0.95	0.86	0.82	0.8	0.63	0.94	0.84	-0.08	-0.64	0.93	-0.58	0.92	0.77
Total Current Liabilities	0.94	0.72	0.98		0.89	0.89	0.08	0.19	0.91	0.43	0.94	-0.82	0.43	0.94	0.81	0.85	0.72	0.69	0.96	0.79	0.1	-0.63	0.93	-0.58	0.91	0.75
Total Stockholder Equity	0.99	0.67	0.92	0.89		0.98	-0.16	0.32	0.94	0.68	0.95	-0.88	0.68	0.96	0.95	0.83	0.86	0.66	0.9	0.95	-0.13	-0.59	0.97	-0.54	0.98	0.75
Property Plant And Equipment Net	0.98	0.74	0.91	0.89	0.98		-0.07	0.39	0.95	0.63	0.94	-0.8	0.63	0.96	0.96	0.85	0.83	0.59	0.91	0.92	-0.13	-0.66	0.97	-0.61	1.0	0.82
Net Debt	-0.02	0.54	-0.03	0.08	-0.16	-0.07		-0.38	0.16	-0.79	0.16	0.27	-0.79	0.08	-0.22	0.4	-0.49	0.16	0.25	-0.44	0.36	0.25	0.06	0.23	-0.01	-0.19
Retained Earnings	0.26	-0.01	0.28	0.19	0.32	0.39	-0.38		0.26	0.45	0.18	-0.29	0.45	0.28	0.39	0.09	0.46	-0.48	0.15	0.42	-0.32	-0.69	0.22	-0.77	0.32	0.54
Accounts Payable	0.97	0.83	0.89	0.91	0.94	0.95	0.16	0.26		0.41	0.99	-0.8	0.41	0.98	0.87	0.95	0.71	0.66	0.96	0.8	0.02	-0.57	0.98	-0.54	0.97	0.71
Cash	0.58	0.09	0.52	0.43	0.68	0.63	-0.79	0.45	0.41		0.41	-0.58	1.0	0.47	0.68	0.22	0.77	0.25	0.35	0.87	-0.3	-0.53	0.51	-0.48	0.59	0.59
Non Current Assets Total	0.98	0.83	0.93	0.94	0.95	0.94	0.16	0.18	0.99	0.41		-0.82	0.41	0.99	0.87	0.95	0.71	0.72	0.99	0.8	0.0	-0.51	0.99	-0.47	0.97	0.69
Non Currrent Assets Other	-0.86	-0.36	-0.85	-0.82	-0.88	-0.8	0.27	-0.29	-0.8	-0.58	-0.82		-0.58	-0.85	-0.84	-0.62	-0.89	-0.59	-0.75	-0.83	0.11	0.55	-0.83	0.5	-0.8	-0.65
Cash And Short Term Investments	0.58	0.09	0.52	0.43	0.68	0.63	-0.79	0.45	0.41	1.0	0.41	-0.58		0.47	0.68	0.22	0.77	0.25	0.35	0.87	-0.3	-0.53	0.51	-0.48	0.59	0.59
Net Receivables	0.99	0.77	0.95	0.94	0.96	0.96	0.08	0.28	0.98	0.47	0.99	-0.85	0.47		0.91	0.92	0.77	0.67	0.97	0.84	-0.07	-0.6	0.99	-0.55	0.98	0.74
Common Stock Shares Outstanding	0.92	0.56	0.86	0.81	0.95	0.96	-0.22	0.39	0.87	0.68	0.87	-0.84	0.68	0.91		0.72	0.92	0.57	0.8	0.92	-0.23	-0.6	0.92	-0.54	0.94	0.77
Non Current Liabilities Total	0.9	0.94	0.82	0.85	0.83	0.85	0.4	0.09	0.95	0.22	0.95	-0.62	0.22	0.92	0.72		0.48	0.67	0.96	0.64	0.05	-0.4	0.92	-0.37	0.89	0.57
Other Current Assets	0.8	0.26	0.8	0.72	0.86	0.83	-0.49	0.46	0.71	0.77	0.71	-0.89	0.77	0.77	0.92	0.48		0.45	0.63	0.9	-0.28	-0.66	0.77	-0.6	0.8	0.76
Other Stockholder Equity	0.7	0.61	0.63	0.69	0.66	0.59	0.16	-0.48	0.66	0.25	0.72	-0.59	0.25	0.67	0.57	0.67	0.45		0.71	0.53	0.21	-0.07	0.72	0.03	0.64	0.27
Total Liab	0.95	0.87	0.94	0.96	0.9	0.91	0.25	0.15	0.96	0.35	0.99	-0.75	0.35	0.97	0.8	0.96	0.63	0.71		0.75	0.05	-0.53	0.96	-0.48	0.94	0.71
Total Current Assets	0.9	0.49	0.84	0.79	0.95	0.92	-0.44	0.42	0.8	0.87	0.8	-0.83	0.87	0.84	0.92	0.64	0.9	0.53	0.75		-0.21	-0.66	0.86	-0.6	0.9	0.78
Short Term Debt	-0.07	0.17	-0.08	0.1	-0.13	-0.13	0.36	-0.32	0.02	-0.3	0.0	0.11	-0.3	-0.07	-0.23	0.05	-0.28	0.21	0.05	-0.21		-0.03	-0.04	-0.05	-0.09	-0.13
Common Stock	-0.58	-0.32	-0.64	-0.63	-0.59	-0.66	0.25	-0.69	-0.57	-0.53	-0.51	0.55	-0.53	-0.6	-0.6	-0.4	-0.66	-0.07	-0.53	-0.66	-0.03		-0.56	0.98	-0.62	-0.86
Inventory	0.99	0.8	0.93	0.93	0.97	0.97	0.06	0.22	0.98	0.51	0.99	-0.83	0.51	0.99	0.92	0.92	0.77	0.72	0.96	0.86	-0.04	-0.56		-0.5	0.99	0.74
Common Stock Total Equity	-0.53	-0.28	-0.58	-0.58	-0.54	-0.61	0.23	-0.77	-0.54	-0.48	-0.47	0.5	-0.48	-0.55	-0.54	-0.37	-0.6	0.03	-0.48	-0.6	-0.05	0.98	-0.5		-0.57	-0.77
Property Plant And Equipment Gross	0.99	0.78	0.92	0.91	0.98	1.0	-0.01	0.32	0.97	0.59	0.97	-0.8	0.59	0.98	0.94	0.89	0.8	0.64	0.94	0.9	-0.09	-0.62	0.99	-0.57		0.79
Current Deferred Revenue	0.75	0.51	0.77	0.75	0.75	0.82	-0.19	0.54	0.71	0.59	0.69	-0.65	0.59	0.74	0.77	0.57	0.76	0.27	0.71	0.78	-0.13	-0.86	0.74	-0.77	0.79

Click cells to compare fundamentals

Sanara Medtech Account Relationship Matchups

Sanara Medtech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.1M	9.8M	36.4M	61.0M	73.9M	77.6M
Short Long Term Debt Total	2.1M	481.4K	425.4K	819.2K	11.8M	12.4M
Other Current Liab	2.2M	2.8M	5.0M	10.8M	10.5M	11.0M
Total Current Liabilities	2.6M	3.5M	6.0M	12.8M	13.8M	14.5M
Total Stockholder Equity	6.6M	6.2M	30.6M	41.8M	44.8M	47.1M
Property Plant And Equipment Net	790.2K	1.1M	2.0M	2.2M	3.3M	3.4M
Net Debt	(4.5M)	26.0K	(18.2M)	(8.1M)	6.6M	7.0M
Retained Earnings	(2.7M)	(7.0M)	(15.2M)	(23.4M)	(28.0M)	(29.4M)
Accounts Payable	337.5K	494.8K	594.0K	1.4M	2.0M	2.1M
Cash	6.6M	455.4K	18.7M	9.0M	5.1M	5.4M
Non Current Assets Total	2.3M	5.3M	11.8M	40.4M	54.9M	57.6M
Non Currrent Assets Other	(2.3M)	(5.3M)	(11.8M)	(40.4M)	(19.0M)	(18.1M)
Cash And Short Term Investments	6.6M	455.4K	18.7M	9.0M	5.1M	5.4M
Net Receivables	1.3M	2.3M	3.0M	7.0M	8.5M	9.0M
Common Stock Shares Outstanding	2.1M	5.7M	7.3M	7.9M	8.3M	8.7M
Liabilities And Stockholders Equity	11.1M	9.8M	36.4M	61.0M	73.9M	77.6M
Non Current Liabilities Total	2.1M	446.1K	222.2K	6.5M	15.5M	16.3M
Other Current Assets	161.9K	611.8K	917.3K	1.1M	608.4K	638.8K
Other Stockholder Equity	(2.1M)	13.2M	45.9M	65.2M	72.9M	76.5M
Total Liab	4.7M	4.0M	6.2M	19.3M	29.3M	30.7M
Total Current Assets	8.9M	4.5M	24.6M	20.6M	19.0M	20.0M
Short Term Debt	117.5K	251.2K	406.6K	627.9K	1.3M	762.3K
Common Stock	3.6K	6.3K	7.7K	8.3K	8.5K	8.1K
Inventory	746.5K	1.1M	2.0M	3.5M	4.7M	5.0M
Common Stock Total Equity	236.6K	3.6K	6.3K	8.3K	9.5K	9.1K
Property Plant And Equipment Gross	790.2K	1.1M	2.4M	3.0M	4.4M	4.7M
Intangible Assets	1.5M	3.1M	4.7M	31.5M	44.9M	47.2M
Net Tangible Assets	(6.2M)	3.1M	25.9M	6.7M	7.7M	8.1M
Property Plant Equipment	790.2K	1.1M	2.0M	1.4M	1.6M	1.7M
Net Invested Capital	(3.3M)	6.2M	30.6M	41.8M	54.5M	57.3M
Net Working Capital	6.2M	942.4K	18.6M	7.8M	5.2M	6.2M
Capital Stock	11.4M	6.3K	7.7K	8.3K	8.5K	8.1K

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:

How To Invest In Sanara

Details

Is Sanara Stock a good investment?

Details

What is Sanara Medtech's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.99)

Revenue Per Share

9.241

Quarterly Revenue Growth

0.352

Return On Assets

(0.05)

Return On Equity

(0.20)

The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanara Total Assets vs Net Tangible Assets Analysis

Total Assets vs Net Tangible Assets

Total Assets vs Net Tangible Assets Correlation Analysis

Correlation Coefficient

Total Assets

Net Tangible Assets

Sanara Medtech fundamental ratios Correlations

Sanara Medtech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sanara Medtech fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Total Assets

Other Current Assets	- 0.89	Non Currrent Assets Other
Non Currrent Assets Other	- 0.88	Total Stockholder Equity
Current Deferred Revenue	- 0.86	Common Stock
Non Currrent Assets Other	- 0.86	Total Assets
Net Receivables	- 0.85	Non Currrent Assets Other
Non Currrent Assets Other	- 0.85	Other Current Liab